CANNABIS SUISSE CORP.
Key Highlights
- Pivoted from cannabis products to property rentals with revenue slashed after major sub-lease ended.
- Reduced losses by 62% year-over-year and cut professional fees by 29%.
- Auditors flagged the company as a 'going concern' with survival in doubt without emergency funding.
Financial Analysis
CANNABIS SUISSE CORP. Annual Report Summary
Explained like we’re chatting over coffee ☕
1. What does this company do? (And how’s it going?)
Cannabis Suisse pivoted from selling cannabis products to renting properties. This year, their income mostly came from leasing space, but a major sub-lease ended in February 2025, slashing revenue. The bottom line? They’re struggling—losing money and scrambling to stay open.
2. Show me the money!
- Revenue: $22,500 this year (down 25% from $30,000 last year).
- Profit: Lost $456,142 (improved from last year’s $1.18M loss).
- Why? Lost a key rental contract, and operating costs (rent, admin) rose to $288,445.
3. Wins 🏆 vs. Mistakes 🤦
Wins:
- Reduced losses by 62% year-over-year.
- Slashed professional fees by 29% (now $55,547).
Mistakes:
- Lost 3 months of revenue from the terminated sub-lease.
- Spent $551,677 settling old debts (using IOUs for lease payoffs).
- Auditors flagged them as a “going concern”—survival in doubt without emergency funding.
4. Cash Check: Critical Condition
🚨 Cash: Just $2,850 left (down from $30M last year!).
🚨 Debt: Owe $218,679 more than they own.
Survival hinges on CEO loans or new investors.
5. Top Risks
- Cash crisis: Could shut down within months without funding.
- Lease instability: More terminations would wipe out their only income.
- Debt burden: Still owe $63,208 in interest payments alone.
6. How do they compare to competitors?
The company didn’t provide clear comparisons. Now competing with property rental firms, but with far fewer resources than typical real estate players.
7. What’s next for 2024?
- Desperately seeking loans or investors.
- Minimal rental income ($22K/year) won’t cover costs.
- Survival = urgent cash injection + no further setbacks.
8. Outside Challenges
- Rising interest rates make borrowing tougher.
- No cannabis business to pivot back to.
Investor Takeaways
🚩 High Risk, Speculative Play 🚩
- Declining Business: Revenue dropped 25%, cash reserves nearly gone.
- Survival Doubts: Auditors warn they may not last another year.
- Transparency Note: Limited details in the annual report—proceed with caution.
Bottom Line: Only consider this if you’re comfortable with extreme risk. The company needs a financial miracle to avoid collapse.
Questions? This is the full picture based on what they shared. Let’s chat if you want to dive deeper! 🌱
Risk Factors
- Cash crisis: Could shut down within months without funding.
- Lease instability: More terminations would eliminate their only income.
- Debt burden: Owe $63,208 in interest payments and $218,679 more than they own.
Why This Matters
This annual report for CANNABIS SUISSE CORP. signals an extremely precarious financial situation, making it a critical read for any current or prospective investor. The company's cash reserves have plummeted to a mere $2,850, a catastrophic drop from $30 million just last year. This, coupled with a 25% revenue decline and a 'going concern' warning from auditors, indicates a high probability of business failure in the near future.
For investors, this filing underscores an exceptionally high-risk, speculative play. The company's survival hinges entirely on securing emergency funding, either through CEO loans or new investors, without which it faces imminent collapse. The lack of clear comparative data and the limited transparency in the report further amplify the risks, suggesting that any investment would be a bet on a last-minute financial rescue rather than a sound business model.
The practical implication is clear: investors should approach CANNABIS SUISSE CORP. with extreme caution. The potential for total loss is significant, and the company's current state suggests it is far from a viable long-term investment. This report serves as a stark warning about the company's critical financial health.
What Usually Happens Next
Following a 'going concern' warning and such dire financial figures, the immediate focus for CANNABIS SUISSE CORP. will be on securing emergency capital. Investors should closely monitor any announcements regarding new loans, equity raises, or strategic partnerships. The company's ability to attract new funding will be the primary determinant of its short-term survival, and a failure to do so quickly could lead to insolvency or bankruptcy proceedings.
Beyond funding, investors should watch for any operational changes aimed at stabilizing revenue or drastically cutting costs. Given the termination of a major sub-lease, the company needs to secure new rental contracts or explore alternative income streams to avoid further revenue erosion. The next quarterly report (10-Q) will be a crucial milestone, providing an update on their cash position and any progress made on securing financing or new business.
If no significant positive developments emerge in the coming months, the company could face delisting from exchanges or be forced to liquidate assets. Investors should prepare for potential further declines in share value and consider the possibility of a complete loss of investment if the company fails to execute a dramatic turnaround.
Financial Metrics
Learn More
Document Information
SEC Filing
View Original DocumentAnalysis Processed
September 14, 2025 at 09:07 AM
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.